Yokogawa’s life business segment provides solutions that support people’s lives and protect health and safety. In addition to our activities in the pharmaceutical and healthcare fields, we are engaged in businesses that ensure everyone has access to safe food and water. To improve productivity throughout the pharmaceutical and food value chains, we utilize our sensing and control technologies to support innovations in products and the production process. In the water industry, we aim to create new value by using the measurement technologies that Yokogawa employs in other fields such as genome analysis and scientific instrumentation.
Business Overview
Strategic Direction and Business Domain
- Strategic Direction
Our life business segment focuses on the pharmaceutical, healthcare, food, and water industries for the enhancement of well-being. Our business vision: “We will lead the world in advancing Bio Industrial Autonomy (BIA) and contribute to a future embracing global harmony.” By using BIA, workloads are reduced, allowing researchers and operators to focus on higher-level research and production site optimization. Taking advantage of Yokogawa’s strengths in measurement, imaging, analysis, diagnosis, integration, and connection, we offer viable solutions to our customers and help them acquire new knowledge and innovate.
- Business Domain
Our business domain encompasses the entire value chain for the pharmaceutical, healthcare, food & beverage, and water industries, from research, development, and production to logistics & services.
Approach with Yokogawa's Accelerate Growth 2023 (AG2023) Mid-term Business Plan
To achieve the goals set out in AG2023, the life business will focus on implementing strategies that target the five business domains of life science, bio-process, pharmaceutical, food, and water. In each of these business domains, it will be important to accelerate growth by targeting markets outside Japan and developing new products.
Contributions to the SDGs
Yokogawa is pursuing the “Three goals” for sustainability based on a vision for society in the year 2050. For the enhancement of well-being, which is one of these goals, our life business focuses on the pharmaceutical, healthcare, water, and food industries. A number of our products have recently been used in research on COVID-19 vaccines and therapeutic agents. We will continue to expand the activities of the life business, which has a direct bearing on broad issues such as aging, the depletion of resources, and food and water shortages.
Areas where the life business contributes, and related SDGs, targeting the year 2030
Contributions in the Fight against the Novel Coronavirus Disease (COVID-19)
New drugs and vaccines are being developed around the world to end the COVID-19 pandemic. We are contributing to the research and development of COVID-19 vaccines and therapeutic drugs at universities and research facilities around the world through the offering of the CellVoyager series of high-content screening systems.
The University of Michigan has developed a method for drug screening that uses AI to analyze the morphological profiles of cells using microscopic images. The CellVoyager CQ1 high-content analysis system, equipped with Yokogawa’s s advanced imaging technology, is being used to capture these images. In 2020, with an urgent need for a treatment method of COVID-19, 1,425 FDA-approved compounds were screened by the CQ1 system for drug repurposing*1, and several compounds with antiviral effects were identified. The study has already been published in the Proceedings of the National Academy of Science (PNAS). As research progresses, it is expected that the elucidation of the mechanism of action of drugs*2 will advance and that the diversion of existing drugs will be efficiently promoted.
We will continue to work with our customers and business partners to find solutions that will aid in the fight against COVID-19.
*1 Drug repurposing: Using a known drug’s effects and side effects to explore applications in other diseases
*2 Mechanism of action: How a drug exerts a therapeutic effect
Related Industries
-
Water & Wastewater
Water resources are finite, and therefore contributing to a sustainable water cycle is one of the Sustainable Development Goals (SDGs). Yokogawa has been providing advanced digital control solutions for the stable supply of clean and safe water, wastewater treatment for protecting the water environment, water loss management and optimization of plant operation for reducing CO2 emissions and running costs. With our leading-edge technologies, dependable products and extensive expertise and experience of diverse water projects around the world, we work with you to provide sustainable water solutions that boost your business and add value throughout the plant lifecycle.
Yokogawa supports a wide range of water control applications in both the municipal and industrial water markets.
-
Food & Beverage
In the food manufacturing industry, in addition to the conventional challenges of achieving both "ensuring food security and safety" and "cost reduction," ｍanufacturers are also working to cope with infectious diseases and labor saving.
YOKOGAWA supports ｍanufacturers to create comfortable workplaces by working closely, coping with challenges together, and proposing ideal factories suitable for operations. -
Pharmaceutical
The pharmaceutical industry currently faces a major challenge in taking full advantage of the opportunities presented in large emerging markets. Now, more than ever, pharmaceutical companies need to introduce lean manufacturing techniques that will enhance profitability. As one of the world's leading industrial automation suppliers, Yokogawa is committed to delivering the best possible solutions for your best manufacturing practices.
Related Products & Solutions
-
Life Science
Yokogawa’s high content analysis systems and dual spinning disk confocal technologies provide high-speed and high-resolution live cell imaging, enabling leading-edge research around the world.